# In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions

> **NCT03371641** · NA · RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 60 (estimated)

## Conditions studied

- Fetal Alcohol Syndrome

## Interventions

- **BEHAVIORAL:** ASQ parental questionnaire
- **BEHAVIORAL:** Development scales
- **BEHAVIORAL:** Scale of Conners
- **BEHAVIORAL:** SCQ Questionnaire
- **PROCEDURE:** Blood sample (mother)
- **PROCEDURE:** Cord blood sample
- **PROCEDURE:** Placenta sample

## Key facts

- **NCT ID:** NCT03371641
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-01-27
- **Primary completion:** 2026-03-27
- **Final completion:** 2026-03-27
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03371641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03371641, "In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03371641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*